Hormonal receptors, human epidermal growth factor receptor-2 and triple negative immunohistochemical typing in women with breast cancer in Kampala, Uganda

Simple item page
dc.contributor.authorMlole, Angela T.
dc.contributor.authorYahaya, James J.
dc.contributor.authorOthieno, Emmanuel
dc.contributor.authorKalungi, Sam
dc.contributor.authorOkwi, Andrew L.
dc.date.accessioned2021-05-26T06:43:54Z
dc.date.available2021-05-26T06:43:54Z
dc.date.issued2020
dc.descriptionFull text article. Also available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745719/en_US
dc.description.abstractThe expression of estrogen and progesterone receptors (ER and PR) and human epidermal growth factor receptor-2 (HER2) has been reported to have an invaluable prognostic role. The aim of this study was to determine the expression of ER, PR and HER2 in women with breast cancer (BC) in Kampala, Uganda. Expression of ER, PR and HER2 was determined immunohistochemically. Logistic regression was performed to determine the effect of the independent factors in predicting the risk of not expressing the breast markers. A two-tailed p<0.05 was regarded to be statistically significant. ER, PR and HER2 were expressed in 53.4%, 46.6% and 18.5%, respectively. ER and PR co-expression was present in 42.7% and 37.9% patients had triple negative breast cancer (TNBC). Age was an independent predictor of expression of ER (AOR = 0.18, 95% CI = 0.062–0.541, p = 0.002) and PR (AOR = 0.35, 95% CI = 0.129–0.968, p = 0.043). The majority of patients in this study had less than 50 years with high tumour grade. Interestingly, most of them had high expression of HER2 with TNBC which are molecular subtypes of BC with poor prognosis. Age was an independent predictor of expression of both ER and PR.en_US
dc.identifier.citationMlole, A. T., Yahaya, J. J., Othieno, E., Kalungi, S., & Okwi, A. L. (2020). Hormonal receptors, human epidermal growth factor receptor-2 and triple negative immunohistochemical typing in women with breast cancer in Kampala, Uganda. International Journal of Women's Health, 12, 1109.en_US
dc.identifier.otherURL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745719/
dc.identifier.urihttp://hdl.handle.net/20.500.12661/3212
dc.language.isoenen_US
dc.publisherDove medical pressen_US
dc.subjectHormonal receptorsen_US
dc.subjectHER2en_US
dc.subjectBreast canceren_US
dc.subjectERen_US
dc.subjectPRen_US
dc.subjectEstrogen receptorsen_US
dc.subjectProgesterone receptorsen_US
dc.subjectHuman epidermal growth factor receptor-2en_US
dc.subjectHER2en_US
dc.subjectFemale canceren_US
dc.subjectHRsen_US
dc.titleHormonal receptors, human epidermal growth factor receptor-2 and triple negative immunohistochemical typing in women with breast cancer in Kampala, Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Angela T. Mlole.pdf
Size:
994.87 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles